TTAB Oppositions 91272599

USPTO Oppositions proceeding 91272599, filed 2021-10-28. Status: Terminated.

Proceeding Facts

Proceeding Number	91272599
Type	Oppositions
Status	Terminated
Filing Date	2021-10-28
Last Activity	2023-03-20
Days Active	1659

Parties

Design Therapeutics, Inc. — Defendant
Genentech, Inc. — Plaintiff

Plaintiff Marks

GENENTECH — Genentech, Inc.
GENENTECH BIOONCOLOGY — Genentech, Inc.
GENENTECH'S THROMBOLYTIC EXPERIENCE — Genentech, Inc.

Defendant Marks

GENETAC — Design Therapeutics, Inc.

Recent Documents

2023-03-20: TERMINATED — Status
2023-03-20: BD DECISION: OPP DISMISSED W/ PREJ — Decisions
2023-03-14: W/DRAW OF OPPOSITION — Withdrawals
2023-03-14: RESPONSE DUE 30 DAYS (DUE DATE) — Scheduling
2023-03-07: MOT TO AMEND APPLICATION — Motions
2023-02-10: EXTENSION OF TIME GRANTED — Extensions
2023-02-10: D MOT FOR EXT W/ CONSENT — Motions
2023-01-13: EXTENSION OF TIME GRANTED — Extensions
2023-01-13: D MOT FOR EXT W/ CONSENT — Motions
2022-11-11: EXTENSION OF TIME GRANTED — Extensions
2022-11-11: D MOT FOR EXT W/ CONSENT — Motions
2022-10-12: EXTENSION OF TIME GRANTED — Extensions
2022-10-12: D MOT FOR EXT W/ CONSENT — Motions
2022-09-13: EXTENSION OF TIME GRANTED — Extensions
2022-09-13: D MOT FOR EXT W/ CONSENT — Motions
2022-08-15: EXTENSION OF TIME GRANTED — Extensions
2022-08-15: D MOT FOR EXT W/ CONSENT — Motions
2022-07-11: EXTENSION OF TIME GRANTED — Extensions
2022-07-11: D MOT FOR EXT W/ CONSENT — Motions
2022-06-15: EXTENSION OF TIME GRANTED — Extensions
2022-06-15: D MOT FOR EXT W/ CONSENT — Motions
2022-05-16: EXTENSION OF TIME GRANTED — Extensions
2022-05-16: D MOT FOR EXT W/ CONSENT — Motions
2022-04-14: EXTENSION OF TIME GRANTED — Extensions
2022-04-14: P MOT FOR EXT W/ CONSENT — Motions
2022-03-17: RESPONSE DUE 30 DAYS (DUE DATE) — Scheduling
2022-02-28: D OPP/RESP TO MOTION — Motions
2022-02-11: P MOT TO AMEND PLEADING/AMENDED PLEADING — Motions
2022-01-18: EXTENSION OF TIME GRANTED — Extensions
2022-01-03: D MOT FOR EXT W/ CONSENT — Motions

Related